Navigation Links
Shanghai CRO Service Alliance Adds Clinical Development Capabilities
Date:4/30/2008

SHANGHAI, China, April 30 /Xinhua-PRNewswire/ -- Today, Tigermed Consulting Ltd. joins Sundia Meditech, HD BioSciences, and NovaSecta in their CRO Service Alliance CROSA that provides R&D solutions for pharmaceutical and biotech companies. Tigermed's expertise in clinical development complements the existing drug discovery and pharmaceutical development capabilities of the alliance.

Sundia Meditech, United PharmaTech, and HD BioSciences entered into a CRO Service Alliance in May 2007 in order to quickly and successfully integrate their chemistry and biology expertise for the increased demands from their clients world-wide. Sundia and United merged into one company in the following months. NovaSecta joined the alliance in February 2008 to further integrate the alliance's work with European pharmaceutical and biotech companies.

Tigermed has a strong track record of providing clinical development services, data management and statistical support to multinational and smaller to medium sized pharmaceutical and biotech companies in US, Europe and Asia. Tigermed is also the clear leader in performing clinical trials in China on innovative New Chemical Entities (NCEs), which makes it an excellent potential partner for the pharmaceutical and biotech companies that Sundia, HD BioSciences and NovaSecta work with.

Through the addition of Tigermed to the alliance, clients can now benefit from a seamlessly integrated full R&D service covering discovery, non-clinical and clinical development.

About Sundia Meditech ( http://www.sundia.com )

Sundia MediTech was founded in Shanghai in 2004 by veterans of the US pharmaceutical industry, and is now a leading CRO company in China. The founding team has talent and track record in organic synthesis, medicinal chemistry, drug design and discovery, process chemistry, cGMP API production, in vitro/vivo PK research, formulation development, analytical
'/>"/>

SOURCE Sundia MediTech Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
2. Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference
3. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
4. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
5. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
6. The Lustgarten Foundation for Pancreatic Cancer Research Launches New Public Service Announcement Featuring Last Lecturer Dr. Randy Pausch
7. SPO Medical Retains American Capital Ventures for Investor Relations Services
8. United BioSource Acquires Leading Publication Planning Software and Services Company
9. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
10. EXL Announces Appointment of Rembert de Villa as Head of Transformation Services
11. CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
Breaking Biology Technology:Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
...n Trials to Begin Later This Year - Only N... - Patient-Friendly (No Needles); No Preserv...No Cold Chain Distribution ...ton,Laboratories, Inc. (OTC Bulletin Board: CARN) ...elSite Biotechnologies, Inc. received a shipment,o...
...stering More Than 180,000 Patient Visits Each Year...ervices Company Aspires to Empower ...OLLS, N.J., Feb. 14 MedeFile,International, Inc. ... in,portable electronic medical records management...ollaborative marketing agreement with Hayes Clinic...
...O, China, Feb. 14 /Xinhua-PRNewswire/ -- Shenzhen ...iotech.com ), the world leader,in the use of umbi...ety of,illnesses, announced that Audrey Jones, the...ay to the United Kingdom (UK) with significant,imp...condition known as,cerebellar atrophy. As the late...
Other Biology Technology:Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration 2Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration 3Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration 4Hayes Clinical Labs to Market MedeFile's Proprietary Electronic Medical Record Management Solution to Patients 2Hayes Clinical Labs to Market MedeFile's Proprietary Electronic Medical Record Management Solution to Patients 3Hayes Clinical Labs to Market MedeFile's Proprietary Electronic Medical Record Management Solution to Patients 4Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility 2Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility 3
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
(Date:12/3/2009)Contents of this message: , , Preliminary Press Conference Topics, Last Call! Press Field Trip to California Academy of Sciences museum, Attention PIOs: Sending Press Releases to Fall meeting, N
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 1Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 5Disparities in cancer care reflect hospital resources U M study finds 54956 1Disparities in cancer care reflect hospital resources U M study finds 54956 2Type 1 diabetes linked to immune response to wheat 54951 1Type 1 diabetes linked to immune response to wheat 54951 2
...PHILADELPHIA (March 17, 2008) -- According to rese... like humans in their responses to many sweet tast...erse range of molecules that humans experience as ...ies. For example, aspartame, a sweetener used by h...However, fruit flies respond positively to most sw...
... Stanford, CACurators at one of the worlds most wi...formation Resource, or TAIR, have joined forces wi...d of information dilemma. It is a first-of-its-kin...r entering important genetics and other biological...em will unclog the information highway and signifi...
...Biotechnology discoveries like the method for cre...nduly hindered or taken hostage by private corpora...1st century, an expert from The Australian Nationa... ANU College of Law takes a broad look at the curr...lectual property rights and biological inventions ...
Other Biology News:Like sweets? You're more like a fruit fly than you think... 2Controlling a sea of information 2Biotechnology needs 21st century patent system: Expert 2
LEVAMISOLE SOLUTION from Invitrogen
Rabbit Anti-Human UCP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Catch and Release® v2.0
Reversible Immunoprecipitation System from Upstate
DTNB from Cayman Chemical
Biology Products: